Elizabeth Stoll, PhD - Publications

2013- Institute of Neuroscience Newcastle University, UK 
Aging, Tumorgenesis, Adult Neural Stem Cell

16/23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Stamp C, Whitehall JC, Smith ALM, Houghton D, Bradshaw C, Stoll EA, Blain AP, Turnbull DM, Greaves LC. Age-associated mitochondrial complex I deficiency is linked to increased stem cell proliferation rates in the mouse colon. Aging Cell. e13321. PMID 33626245 DOI: 10.1111/acel.13321  0.52
2018 Stamp C, Zupanic A, Sachdeva A, Stoll EA, Shanley DP, Mathers JC, Kirkwood TBL, Heer R, Simons BD, Turnbull DM, Greaves LC. Predominant Asymmetrical Stem Cell Fate Outcome Limits the Rate of Niche Succession in Human Colonic Crypts. Ebiomedicine. PMID 29748033 DOI: 10.1016/J.Ebiom.2018.04.017  0.52
2016 Stoll EA, Karapavlovic N, Rosa H, Woodmass M, Rygiel K, White K, Turnbull DM, Faulkes CG. Naked mole-rats maintain healthy skeletal muscle and Complex IV mitochondrial enzyme function into old age. Aging. PMID 27997359 DOI: 10.18632/aging.101140  0.52
2016 Lin H, Patel S, Affleck VS, Wilson I, Turnbull DM, Joshi AR, Maxwell R, Stoll EA. Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro-Oncology. PMID 27365097 DOI: 10.1093/Neuonc/Now128  0.52
2015 Stoll EA, Makin R, Sweet IR, Trevelyan AJ, Miwa S, Horner PJ, Turnbull DM. Neural Stem Cells in the Adult Subventricular Zone Oxidize Fatty Acids to Produce Energy and Support Neurogenic Activity. Stem Cells (Dayton, Ohio). 33: 2306-19. PMID 25919237 DOI: 10.1002/Stem.2042  0.44
2014 Bauer R, Kaiser M, Stoll E. A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population. Plos One. 9: e111219. PMID 25409511 DOI: 10.1371/Journal.Pone.0111219  0.44
2013 Stoll EA, Horner PJ, Rostomily RC. The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment. Aging Cell. 12: 733-41. PMID 23711239 DOI: 10.1111/Acel.12104  0.44
2012 Mikheev AM, Stoll EA, Ramakrishna R, Mikheeva SA, Horner PJ, Rostomily RC. Geropotency: increased malignant potential of aging neural progenitors. Aging. 4: 854-5. PMID 23257545  0.44
2012 Mikheev AM, Ramakrishna R, Stoll EA, Mikheeva SA, Beyer RP, Plotnik DA, Schwartz JL, Rockhill JK, Silber JR, Born DE, Kosai Y, Horner PJ, Rostomily RC. Increased age of transformed mouse neural progenitor/stem cells recapitulates age-dependent clinical features of human glioma malignancy. Aging Cell. 11: 1027-35. PMID 22958206 DOI: 10.1111/Acel.12004  0.44
2011 Stoll EA, Habibi BA, Mikheev AM, Lasiene J, Massey SC, Swanson KR, Rostomily RC, Horner PJ. Increased re-entry into cell cycle mitigates age-related neurogenic decline in the murine subventricular zone. Stem Cells (Dayton, Ohio). 29: 2005-17. PMID 21948688 DOI: 10.1002/Stem.747  0.44
2011 Stoll EA, Cheung W, Mikheev AM, Sweet IR, Bielas JH, Zhang J, Rostomily RC, Horner PJ. Aging neural progenitor cells have decreased mitochondrial content and lower oxidative metabolism. The Journal of Biological Chemistry. 286: 38592-601. PMID 21900249 DOI: 10.1074/Jbc.M111.252171  0.44
2010 Mikheev AM, Horner PJ, Ramakrishna R, Maxwell JP, Stoll EA, Rostomily RC. Reply to: age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology. 34: 130. PMID 20068359 DOI: 10.1159/000274805  0.44
2009 Mikheev AM, Stoll EA, Mikheeva SA, Maxwell JP, Jankowski PP, Ray S, Uo T, Morrison RS, Horner PJ, Rostomily RC. A syngeneic glioma model to assess the impact of neural progenitor target cell age on tumor malignancy. Aging Cell. 8: 499-501. PMID 19489742 DOI: 10.1111/J.1474-9726.2009.00494.X  0.44
2006 Hnasko TS, Perez FA, Scouras AD, Stoll EA, Gale SD, Luquet S, Phillips PE, Kremer EJ, Palmiter RD. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proceedings of the National Academy of Sciences of the United States of America. 103: 8858-63. PMID 16723393 DOI: 10.1073/Pnas.0603081103  0.44
2005 Talk A, Stoll E, Gabriel M. Cingulate cortical coding of context-dependent latent inhibition. Behavioral Neuroscience. 119: 1524-32. PMID 16420156 DOI: 10.1037/0735-7044.119.6.1524  0.84
2005 Smith JT, Dungan HM, Stoll EA, Gottsch ML, Braun RE, Eacker SM, Clifton DK, Steiner RA. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse Endocrinology. 146: 2976-2984. PMID 15831567 DOI: 10.1210/En.2005-0323  0.44
Low-probability matches
2019 Gee L, Millar B, Leslie J, Richardson C, Jurk D, Luli S, Zaki MYW, LeBeau F, Stoll E, Jones D, Oakley F. PS-121-Obeticholic acid limits cholestasis induced cognitive decline by maintaining blood-brain barrier integrity and preserving neuronal health Journal of Hepatology. 70: e75-e76. DOI: 10.1016/S0618-8278(19)30133-1  0.01
2017 Gándara C, Affleck V, Stoll EA. Manufacture of third-generation lentivirus for preclinical use, with process development considerations for translation to Good Manufacturing Practice (GMP). Human Gene Therapy Methods. PMID 29212357 DOI: 10.1089/hgtb.2017.098  0.01
2017 White M, Whittaker R, Gándara C, Stoll EA. A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies. Human Gene Therapy Methods. 28: 163-176. PMID 28817344 DOI: 10.1089/Hgtb.2017.096  0.01
2017 White M, Whittaker R, Stoll EA. A guide to approaching regulatory considerations for lentiviral-mediated gene therapies. Human Gene Therapy Methods. PMID 28605938 DOI: 10.1089/hum.2017.096  0.01
2017 Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Frontiers in Cell and Developmental Biology. 5: 43. PMID 28491867 DOI: 10.3389/fcell.2017.00043  0.01
2014 Stoll EA. Advances toward regenerative medicine in the central nervous system: challenges in making stem cell therapy a viable clinical strategy. Molecular and Cellular Therapies. 2: 12. PMID 26056581 DOI: 10.1186/2052-8426-2-12  0.01
2012 Brognaro E, Ghods A, Feinstein D, Glick R, Connolly KJ, Meetze K, Boudrow A, Gyuris J, Han M, Hingtgen S, Figueiredo J, Farrar C, Farrar C, Deubgen M, Martinez-Quintanilla J, ... ... Stoll EA, et al. LAB-TUMOR MODELS (IN VIVO/IN VITRO) Neuro-Oncology. 14: vi160-vi164. DOI: 10.1093/Neuonc/Nos241  0.01
Hide low-probability matches.